Search research articles
Contact Us
Filters
Showing results (671-680 of 979) with videos related to
Page
of 98
Sort By:
Cancers
|
February 10, 2026
Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. <i>Cancers</i> 2021, <i>13</i>, 3876
Chiao-En Wu, Ahmed Khairallah Mahdi, Chen-Yang Huang, et al.
Cells
|
April 12, 2022
Long Noncoding RNA LOC550643 Acts as an Oncogene in the Growth Regulation of Colorectal Cancer Cells
Hsuan Franziska Wu, Tzung-Ju Lu, Yi-Hao Lo, et al.
Bioorganic Chemistry
|
August 9, 2025
The LSD1/HDAC dual-target inhibitor for cancer therapy: Challenge and opportunity
Dan-Dan Shen, Hao-Qian Zhang, Chen-Chen Ren, et al.
Drug Development Research
|
September 10, 2024
The mechanism of action and chemical synthesis of FDA newly approved drug molecules
Dan-Dan Shen, Yue-Lin Zhang, Xiang Li, et al.
Asia Pacific Journal of Clinical Nutrition
|
August 21, 2007
Intake of vitamin A-rich foods and lung cancer risk in Taiwan: with special reference to garland chrysanthemum and sweet potato leaf consumption
Yi-Ru Jin, Meei-Shyuan Lee, Jang-Hwa Lee, et al.
Frontiers in Cell and Developmental Biology
|
August 6, 2021
<i>LOC550643</i>, a Long Non-coding RNA, Acts as Novel Oncogene in Regulating Breast Cancer Growth and Metastasis
Kuo-Wang Tsai, Kian-Hwee Chong, Chao-Hsu Li, et al.
Frontiers in Immunology
|
September 9, 2022
Efficacy and safety of biological agents for the treatment of pediatric patients with psoriasis: A bayesian analysis of six high-quality randomized controlled trials
Xiao-Ce Cai, Yi Ru, Liu Liu, et al.
Frontiers in Aging Neuroscience
|
October 16, 2024
Coumarin-chalcone derivatives as dual NLRP1 and NLRP3 inflammasome inhibitors targeting oxidative stress and inflammation in neurotoxin-induced HMC3 and BE(2)-M17 cell models of Parkinson's disease
Te-Hsien Lin, Ya-Jen Chiu, Chih-Hsin Lin, et al.
European Journal of Medicinal Chemistry
|
July 25, 2024
A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects
Yi-Ru Bai, Dong-Jie Seng, Ying Xu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 15, 2023
Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial
Wen-Kuan Huang, Hung-Chih Hsu, Tsai-Sheng Yang, et al.
Page
of 98
Search research articles
Search
Showing results (671-680 of 979) with videos related to
Sort By:
Page
of 98
Cancers
|
February 10, 2026
Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. <i>Cancers</i> 2021, <i>13</i>, 3876
Chiao-En Wu, Ahmed Khairallah Mahdi, Chen-Yang Huang, et al.
Cells
|
April 12, 2022
Long Noncoding RNA LOC550643 Acts as an Oncogene in the Growth Regulation of Colorectal Cancer Cells
Hsuan Franziska Wu, Tzung-Ju Lu, Yi-Hao Lo, et al.
Bioorganic Chemistry
|
August 9, 2025
The LSD1/HDAC dual-target inhibitor for cancer therapy: Challenge and opportunity
Dan-Dan Shen, Hao-Qian Zhang, Chen-Chen Ren, et al.
Drug Development Research
|
September 10, 2024
The mechanism of action and chemical synthesis of FDA newly approved drug molecules
Dan-Dan Shen, Yue-Lin Zhang, Xiang Li, et al.
Asia Pacific Journal of Clinical Nutrition
|
August 21, 2007
Intake of vitamin A-rich foods and lung cancer risk in Taiwan: with special reference to garland chrysanthemum and sweet potato leaf consumption
Yi-Ru Jin, Meei-Shyuan Lee, Jang-Hwa Lee, et al.
Frontiers in Cell and Developmental Biology
|
August 6, 2021
<i>LOC550643</i>, a Long Non-coding RNA, Acts as Novel Oncogene in Regulating Breast Cancer Growth and Metastasis
Kuo-Wang Tsai, Kian-Hwee Chong, Chao-Hsu Li, et al.
Frontiers in Immunology
|
September 9, 2022
Efficacy and safety of biological agents for the treatment of pediatric patients with psoriasis: A bayesian analysis of six high-quality randomized controlled trials
Xiao-Ce Cai, Yi Ru, Liu Liu, et al.
Frontiers in Aging Neuroscience
|
October 16, 2024
Coumarin-chalcone derivatives as dual NLRP1 and NLRP3 inflammasome inhibitors targeting oxidative stress and inflammation in neurotoxin-induced HMC3 and BE(2)-M17 cell models of Parkinson's disease
Te-Hsien Lin, Ya-Jen Chiu, Chih-Hsin Lin, et al.
European Journal of Medicinal Chemistry
|
July 25, 2024
A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects
Yi-Ru Bai, Dong-Jie Seng, Ying Xu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 15, 2023
Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial
Wen-Kuan Huang, Hung-Chih Hsu, Tsai-Sheng Yang, et al.
Page
of 98